TABLE 1.
Mutation | Trypsin stabilitya | Toxicityb | BBMV protein bindingc |
---|---|---|---|
Q133R | Stable | Nontoxic | + |
I132S | Stable | Nontoxic | + |
I132L | Stable | Nontoxic | + |
I132V | Stable | Nontoxic | + |
I132N | Stable | Nontoxic | + |
R131L | Stable | Reduced | + |
R131C | Stable | No change | NT |
R131S | Stable | No change | NT |
M130I | Stable | No change | NT |
M137T | Stable | No change | NT |
F134L | Stable | Enhancedd | NT |
Q133H | Stable | No change | NT |
I132V-D136Y | Stable | Reduced | NT |
M130I-R131L | Unstable | ||
I132F-N135S | Unstable | ||
F134A-M137I | Unstable |
As demonstrated in Fig. 1.
LC50 were determined with infected E. coli cells as described in Materials and Methods. Nontoxic means no toxicity was evident with the most concentrated suspension of either M13-infected cells or of E. coli clones (undiluted cells at 2 × 108 to 3 × 108 ml−1). No change means that the LC50 was within the same range as that of cells infected with the wild type. Reduced means that there was a >10-fold increase in the LC50.
As shown in Fig. 2. NT, not tested; +, protein binding evident.
The LC50 was 106 cells (6.6 × 105 to 1.3 × 106 for 95% confidence limits) for the F134L mutant versus 1.9 × 106 (1.3 × 106 to 3.3 × 106 for 95% confidence limits) for the wild-type infected cells.